Leveraging genetics to treat neurological diseases.
Voyager Therapeutics is a clinical-stage gene therapy company developing disease-modifying neurotherapeutics for severe neurological diseases. The company leverages validated genetic targets and multiple therapeutic modalities, including its TRACER platform and non-viral approaches, with a pipeline focused on Alzheimer's disease treatments.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2015
Apr 2015
Feb 2014
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
